RGS7 Antikörper (C-Term)
Kurzübersicht für RGS7 Antikörper (C-Term) (ABIN954534)
Target
Alle RGS7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 447-477, C-Term
-
Spezifität
- This antibody recognizes Human RGS7 (C-term).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 447-477 amino acids from the C-terminal region of Human RGS7. Genename: RGS7
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- RGS7 (Regulator of G-Protein Signaling 7 (RGS7))
-
Andere Bezeichnung
- RGS7
-
Hintergrund
- RGS7 inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(o)-alpha is specifically enhanced by the RGS6/GNG5 dimer. May play a role in synaptic vesicle exocytosis. May play important role in the rapid regulation of neuronal excitability and the cellular responses to short-lived stimulations (By similarity).Synonyms: Regulator of G-protein signaling 7
-
Molekulargewicht
- 57668 Da
-
Gen-ID
- 6000
-
NCBI Accession
- NP_002915
-
Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-